Form 4: Aron R. English Acquires Stock Options in Anebulo Pharmaceuticals

Aron R. English, a director and 10% owner of Anebulo Pharmaceuticals, acquired stock options to purchase 27,647 shares of common stock on April 4, 2025.

Summary

• Aron R. English, a director and 10% owner of Anebulo Pharmaceuticals, Inc., filed a Form 4.
• On April 4, 2025, English acquired stock options to purchase 25,000 shares of common stock at an exercise price of $1.02.
• These options vest on the earlier of April 4, 2026, or the date of the 2026 annual meeting of shareholders and expire on April 3, 2035.
• Additionally, English acquired stock options to purchase 2,647 shares of common stock at an exercise price of $1.02, vesting and expiring on the same dates.
• Following these transactions, English directly owns options to purchase a total of 27,647 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock option acquisition by a company insider. While insider ownership can be a positive signal, this is a routine transaction.

Positives

• The acquisition of stock options by a director and 10% owner could be seen as a positive sign, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders. This filing indicates changes in beneficial ownership of Anebulo Pharmaceuticals' securities by a director and significant shareholder.

Stakeholder Impact

• The acquisition of stock options by a director and significant shareholder could potentially increase investor confidence.

Key Dates

Keywords

Form 4, Stock Options, Beneficial Ownership, Anebulo Pharmaceuticals, English, Acquisition